Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Status:
Completed
Trial end date:
2017-05-16
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and exploratory efficacy of
SF0166 Topical Ophthalmic Solution in patients with Diabetic Macular Edema (DME).